ATE458749T1 - Neuartige mit taxan verwandte peptide und deren verwendung - Google Patents
Neuartige mit taxan verwandte peptide und deren verwendungInfo
- Publication number
- ATE458749T1 ATE458749T1 AT06026026T AT06026026T ATE458749T1 AT E458749 T1 ATE458749 T1 AT E458749T1 AT 06026026 T AT06026026 T AT 06026026T AT 06026026 T AT06026026 T AT 06026026T AT E458749 T1 ATE458749 T1 AT E458749T1
- Authority
- AT
- Austria
- Prior art keywords
- related peptides
- taxan
- novel
- novel taxan
- peptides
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 229940123237 Taxane Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- 230000000861 pro-apoptotic effect Effects 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06026026A EP1932852B1 (de) | 2006-12-15 | 2006-12-15 | Neuartige mit Taxan verwandte Peptide und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458749T1 true ATE458749T1 (de) | 2010-03-15 |
Family
ID=37964135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06026026T ATE458749T1 (de) | 2006-12-15 | 2006-12-15 | Neuartige mit taxan verwandte peptide und deren verwendung |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1932852B1 (de) |
| AT (1) | ATE458749T1 (de) |
| DE (1) | DE602006012515D1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11021514B2 (en) | 2016-06-01 | 2021-06-01 | Athira Pharma, Inc. | Compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110131679A2 (en) * | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| JP2004520803A (ja) * | 2000-04-21 | 2004-07-15 | コリクサ コーポレイション | 尋常性挫瘡の治療および診断のための組成物および方法 |
| CA2480419A1 (en) * | 2002-03-28 | 2003-10-09 | Yamanouchi Pharmaceutical Co., Ltd. | Antiopoietin-related growth factor |
-
2006
- 2006-12-15 AT AT06026026T patent/ATE458749T1/de not_active IP Right Cessation
- 2006-12-15 DE DE602006012515T patent/DE602006012515D1/de active Active
- 2006-12-15 EP EP06026026A patent/EP1932852B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006012515D1 (de) | 2010-04-08 |
| EP1932852B1 (de) | 2010-02-24 |
| EP1932852A1 (de) | 2008-06-18 |
| EP1932852A8 (de) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201001054B (en) | Peptide with reduced dimer formation | |
| CY1113188T1 (el) | Τροποποιημενα fgf-21 πολυπεπτιδια και οι χρησεις τους | |
| CY1113199T1 (el) | Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης | |
| CY1120206T1 (el) | Μεθοδοι για τη συγκλινουσα συνθεση παραγωγων καλιχεαμικινης | |
| ATE523544T1 (de) | Alkylierte aminopropylierte ethyendiamine und verwendungen davon | |
| MY161534A (en) | Methods of purifying polypeptides | |
| DE602007012559D1 (de) | H die schleimhaut | |
| EA201001356A1 (ru) | Новые замещенные имидазохинолины | |
| BRPI0818672A2 (pt) | 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase | |
| CL2007003774A1 (es) | Compuestos derivados de quinazolina sustituidos, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, aterosclerosis y artritis. | |
| ECSP11010760A (es) | Derivados de quinoxalindiona | |
| HN2011001697A (es) | Compuesto amino pirazol | |
| EP2195331A4 (de) | Synthetische, apolipoprotein e nachahmende polypeptide und anwendungsverfahren | |
| ATE486079T1 (de) | Azatricyclische verbindungen und deren verwendung | |
| ATE514765T1 (de) | Azeotropartige zusammensetzungen mit 1,1,1,2,3,3- hexafluor-3-methoxypropan und 1-brompropan | |
| CR20110202A (es) | Antagonistas de la via hedgehog de ftalazina disustituida | |
| CR11126A (es) | Inhibicion de metastasis de tumor por anticuerpos anti neuropilina 2 | |
| NO20081102L (no) | Anvendelse av modifiserte trematerialer for fremstilling av gjenstander | |
| ATE523543T1 (de) | Alkylierte aminoproyliertes methylen-di- (cyclohexylamin) und verwendungen davon | |
| DE502006004472D1 (de) | Organische elektrolumineszenzvorrichtungen | |
| CL2008003602A1 (es) | Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos. | |
| ATE458749T1 (de) | Neuartige mit taxan verwandte peptide und deren verwendung | |
| EA200971103A1 (ru) | Иммуноцитокины для лечения рака в сочетании с химиотерапевтическими агентами | |
| DE602007002716D1 (de) | Neuroprotektive verbindungen und deren verwendungen | |
| CL2008000865A1 (es) | Compuestos derivados de benzimidazol-2-ona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de un trastorno psicotico o un deterioro cognitivo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |